Speaker Profile
Hugo Miguel Baptista Carreira Dos Santos

Hugo Miguel Baptista Carreira Dos Santos PhD

Research and Clinical Research, Biochemistry and Molecular Genetics
Lisbon, Lisbon, Portugal

Connect with the speaker?

Dr. Hugo Miguel is an experienced scientist in the field of mass spectrometry and proteomics. He is skilled in Mass Spectrometry, Protein Chemistry, Spectroscopy, High-Performance Liquid Chromatography (HPLC), Bioinformatics, and Molecular Biology. Strong research professional with a Ph.D focused in Biochemistry - Proteomics, he has published 86 articles in international peer-review journals that have attracted a high number of citations (over 970 to date). The 2010 publication in Chem. Soc. Rev. has alone been cited over 140 times, and ten other papers received over 20 citations, many related to innovative approaches for MS protein identification and quantification. 73% of these papers were published in first quartile high impact factor publications.

Graduated in Applied Chemistry – Bioorganic Chemistry from the Universidade NOVA de Lisboa, then he joined a Ph.D. program in Biochemistry at NOVA in the laboratory of Prof. Capelo and Prof. Moura at REQUIMTE, Portugal, and Prof. Corthals at Turku Centre for Biotechnology, Finland, to work with state-of-the-art MS instrumentation for biomedical research. At the end of 2010, he took up a post-doc at the University of Vigo to work on bio-organics supramolecular structures involving synthetic molecules, metals, and proteins. In 2011, he moved to the laboratory of Prof. Francesc Avilés at the Institute for Biomedicine and Biotechnology (Barcelona, Spain). In April 2012, he moved to FCT-NOVA to develop my post-doctoral research to characterize molecular signatures associated with aging, chronic kidney diseases, and cancer. Since December 2016 he has started as an assistant researcher, FCT-Investigator Programme to investigate the role of protein phosphorylation in aging gaining insights into the role of the protein phosphorylation mechanisms of disease initiation, progression, and response to treatment.